Roche

Roche

A biotechnology company with a focus on developing pharmaceuticals and diagnostics. It was founded in 1896 and is located in Basel, Switzerland.

Roche is a Switzerland-based biotechnology company that develops therapeutics and diagnostics for oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. The company has more than 900,000 employees throughout 100 countries. It states that it is the world's largest biopharmaceutical company and the lead supplier of in vitro diagnostics.

Product

The company has research and development in progress for pharmaceuticals and diagnostics for haemophilia, women's health, inflammatory bowel disease, and neuroscience. The facilities for this research are located in the United States, Austria, Germany, Poland, Switzerland, South Africa, and China.Roche conducts clinical trials and once they are successfully completed the pharmaceuticals are produced in an experimental lab to ensure scalability. The company has manufacturing facilities for its therapeutics, including facilities for its biologics.

Roche offers more than 40 pharmaceuticals, including Hemlibra, Micera, and Tamiflu.

Timeline

December 11, 2020
Roche launches high-throughput COVID-19 antigen test in Europe.

November 16, 2020
Lead Pharma enters into a collaboration and license agreement with Roche to develop oral small molecules to treat a broad range of immune-mediated diseases.

December 2019
Roche completes its acquisition of Spark Therapeutics for $4.3 billion.
March 2009
Genentech and Roche merge.
1968
Roche enters the diagnostics market.
1896
Roche is founded by Fritz Hoffmann-La Roche in Switzerland.

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Roche to launch laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients

F. Hoffmann-La Roche Ltd

Web

October 13, 2020

Roche to present new data across 16 blood disorders at the American Society of Hematology 2020 Annual Meeting

F. Hoffmann-La Roche Ltd

Web

November 5, 2020

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Alex Keown
April 16, 2021
BioSpace
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
BioSpace
April 15, 2021
BioSpace
Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced the appointments of Luca Scavo as Chief Financial Officer (CFO), effective June 1, 2021, and Julie H. McHugh to its Board of Directors, effective immediately.
BioSpace
April 12, 2021
BioSpace
Second Phase 3 trial undertaken in collaboration with NIAID to announce results , both using subcutaneous administration of REGEN-COV in asymptomatic individuals without prior COVID-19 infection
BioSpace
April 12, 2021
BioSpace
REGEN-COV rapidly protected household contacts from exposure to SARS-CoV-2 at home, with 72% protection against symptomatic infections in the first week, and 93% in subsequent weeks
Regeneron Pharmaceuticals, Inc.
April 12, 2021
www.prnewswire.com:443
/PRNewswire/ -- REGEN-COV rapidly protected household contacts from exposure to SARS-CoV-2 at home, with 72% protection against symptomatic infections in the...
Regeneron Pharmaceuticals, Inc.
April 12, 2021
www.prnewswire.com:443
/PRNewswire/ -- Second Phase 3 trial undertaken in collaboration with NIAID to announce results today, both using subcutaneous administration of REGEN-COV in...
Melanie Senior
April 1, 2021
Nature Biotechnology
Private biotech firms are awash with funding, raising record-breaking sums in 2020. Melanie Senior reports.
Ben Adams
March 30, 2021
FierceBiotech
Just over a year after Wave Life Sciences cut staffers, threw out a Duchenne muscular dystrophy med and saw its Huntington's disease drug flop in a key test, the waves come crashing down again for the biotech.
Nick Paul
March 23, 2021
FierceBiotech
Roche has stopped a phase 3 Huntington's disease clinical trial after an interim review of the data. The preplanned review found no new safety signals associated with Ionis Pharmaceuticals-partnered antisense drug tominersen, suggesting lack of efficacy may have driven the decision to stop the trial.
Conor Hale
March 18, 2021
FierceBiotech
Roche launched a new COVID-19 test to help researchers monitor emerging variants and track mutations in the coronavirus' genome that may make the disease more contagious or more deadly.
Conor Hale
March 15, 2021
FierceBiotech
Roche has inked a $1.8 billion, all-cash deal for GenMark Diagnostics, to acquire its molecular tests designed to screen patient samples for multiple infections simultaneously.
Richard Smith
March 8, 2021
TechCrunch
As an early-stage founder, how do you identify the right investors? Or know how to hire the best possible team to set up your company for growth? Should you bootstrap, and if so, how do you do it successfully? How do you nail virtual pitch meetings? What about product market fit? Board construction and good [...]
Regeneron Pharmaceuticals, Inc.
February 26, 2021
www.prnewswire.com:443
/PRNewswire/ -- EU member states can utilize the positive CHMP opinion when making national decisions about use of the antibody cocktail, prior to a potential...
Amirah Al Idrus
February 12, 2021
FierceBiotech
Roche's bispecific antibody matched Regeneron's blockbuster Eylea in four phase 3 studies comparing the two in diabetic macular edema and wet age-related macular degeneration. The studies found the experimental drug did no worse than the incumbent despite a majority of the patients going longer between injections.
Ben Adams
February 5, 2021
FierceBiotech
As Eli Lilly and Biogen stir up hope in the Alzheimer's Disease drug space, Roche's pharma CEO is not getting dragged into hype over its effort gantenerumab.
Conor Hale
February 4, 2021
FierceBiotech
The company launched 15 different tests for COVID-19 over the past year, including both rapid, point-of-care solutions and high-throughput, centralized laboratory diagnostics.
Ben Adams
February 4, 2021
FierceBiotech
Swiss major Roche is dumping a series of cancer, autoimmune and respiratory drugs in mid-to-late stage tests.
Althea
February 1, 2021
www.prnewswire.com:443
/PRNewswire/ -- Althea UK and Ireland - the leading medical technology services provider- has announced that they are now offering high quality and...
Amirah Al Idrus
January 28, 2021
FierceBiotech
Roche's venture arm is joining the likes of Sofinnova Partners and AbbVie in backing Italy's Enthera Pharmaceuticals, bringing the diabetes-focused biotech's series A round to €35 million ($42 million). The funding will bankroll the company's lead program, Ent001, to clinical proof of concept.
Conor Hale
January 28, 2021
FierceBiotech
Alzheimer's disease has proven to be stubbornly difficult to unravel, but Roche aims to tap into a new tool that promises to accelerate the process: the quantum computer.
SHOW MORE

References

Page 1 of 2
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.